Also mentions ALK:
Emergence of new ALK mutations at relapse of neuroblastoma.
x hide permanently

Combination therapy in neuroblastoma: It`s all about the mix

Health News

The combination of two cell division inhibitors causes malignant nervous system tumors to die off, as scientists from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ) have shown in experimental studies.The combination strategy could be the key to new targeted therapies against this aggressive type of tumor. The Hopp Children’s Cancer Center at […]

The post Combination therapy in neuroblastoma: It`s all about the mix appeared first on Healthcanal.com.

Mentions: ALK